Follow-The-Filings

Security · featured owners

ACRV Acrivon Therapeutics Inc.

Health Care COMMON STOCK Equity among managers we track

ACRV (Acrivon Therapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$60.39M -$80.56M -$77.9M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $129.69M $181.63M $120.44M
Total non-current assets * $8.57M $14.96M $9.27M
Total assets $138.26M $196.59M $129.72M
Total current liabilities $13.3M $17.21M $15.66M
Total non-current liabilities * $3.77M $2.59M $1.54M
Total equity $121.2M $176.79M $112.52M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$42.64M -$65.67M -$63.66M
Cash from investing $50.72M -$51.77M $66.1M
Cash from financing -$1.55M $121.03M -$0.749M
Net change in cash $6.52M $3.59M $1.69M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders